EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression

Uri Bright, Irit Akirav iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Uri Bright und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, School of Psychological Sciences, University of Haifa, Haifa 3498838, Israel. Hauptthemen laut MEDLINE: Cannabidiol, MicroRNAs. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) is a potential antidepressant agent. We examined the association between the antidepressant effects of CBD and alterations in brain microRNAs in the unpredictable chronic mild stress (UCMS) model for depression. UCMS male rats were injected with vehicle or CBD (10 mg/kg) and tested for immobility time in the forced swim test. Alterations in miRNAs (miR16, miR124, miR135a) and genes that encode for the 5HT1a receptor, the serotonergic transporter SERT, β-catenin, and CB1 were examined. UCMS increased immobility time in a forced swim test (i.e., depressive-like behavior) and altered the expression of miRNAs and mRNA in the ventromedial prefrontal cortex (vmPFC), raphe nucleus, and nucleus accumbens. Importantly, CBD restored UCMS-induced upregulation in miR-16 and miR-135 in the vmPFC as well as the increase in immobility time. CBD also restored the UCMS-induced decrease in htr1a, the gene that encodes for the serotonergic 5HT1a receptor; using a pharmacological approach, we found that the 5HT1a receptor antagonist WAY100135 blocked the antidepressant-like effect of CBD on immobility time. Our findings suggest that the antidepressant effects of CBD in a rat model for depression are associated with alterations in miR-16 and miR-135 in the vmPFC and are mediated by the 5HT1a receptor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolMicroRNAsRatsMaleAnimalsDepressionAntidepressive AgentsBrainPrefrontal CortexReceptor, Serotonin, 5-HT1ADisease Models, Animal

Stichwörter der Autor:innen

5-HT1a receptorCB1 receptorcannabidioldepressionmicroRNAsprefrontal cortex

Substanzen

CannabidiolAntidepressive AgentsMicroRNAsReceptor, Serotonin, 5-HT1AMIRN124 microRNA, ratMIRN16 microRNA, rat

Autor:innen und Institutionen

  • Department of Psychology, School of Psychological Sciences, University of Haifa, Haifa 3498838, Israel.
  • The Integrated Brain and Behavior Research Center (IBBRC), University of Haifa, Haifa 3498838, Israel.

ORCID-Profile: Irit Akirav

Förderung

  • Israel Science Foundation

Zitieren

APA

Bright, U., & Akirav, I. (2023). Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032052

Vancouver

Bright U, Akirav I. Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032052

BibTeX
@article{Bright2023,
  author = {Bright, Uri and Akirav, Irit},
  title = {Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032052}
}
Kostenlos starten →